Abbott Biotech Ventures, Inc.

DAG Ventures - www.dagventures.com

DAG Ventures is a venture capital partnership investing in and helping outstanding entrepreneurs create leading, long-term companies across a range of markets. Today, the partnership is privileged to work with world-class entrepreneurs as they build tomorrow's leaders in the information technology, energy and life science sectors. DAG Ventures invests in companies with proven technology, from the prototype stage onward.

HealthCare Ventures - www.hcven.com

HealthCare Ventures is a leading venture capital firm specializing in life science industry investing. At HealthCare Ventures we invest primarily in early-stage companies. Since 1985, we have maintained a constant objective to support entrepreneurs and to generate above average returns for our limited partners. Over the past 22 years, HealthCare Ventures has raised $1.6 billion in eight funds, and has invested in more than 80 companies. Notable HealthCare Ventures investments include public companies such as Critical Therapeutics, Dendreon Pharmaceuticals, Human Genome Sciences, LeukoSite, MedImmune, Middlebrook Pharmaceuticals, OraSure, Replidyne, Inc., Shire Pharmaceuticals, Verenium Corp, and Vicuron Pharmaceuticals.

Kleiner Perkins Caufield & Byers - www.kpcb.com

Since its founding in 1972, Kleiner Perkins Caufield & Byers has backed entrepreneurs in 475 ventures, including AOL, Align, Amazon.com, Citrix, Compaq Computer, Electronic Arts, Genentech, Genomic Health, Google, IDEC Pharmaceuticals, Intuit, Juniper Networks, Netscape, Lotus, LSI Logic, Sun Microsystems, Symantec, Verisign, and Xilinx. More than 150 of the firm's portfolio companies have gone public. Many other ventures have achieved success through mergers and acquisitions. KPCB has broadly invested in both life sciences and information technology since inception in 1972. In the last few years, KPCB has expanded its focus to include Greentech and pandemic preparedness.

Northgate Capital - www.northgatecapital.com

Northgate Capital is a closely-held partnership with a singular focus on delivering superior financial returns to its investors through private equity investments, venture capital, growth capital, and distressed/special opportunities. Since the late 1990s, Northgate has offered its investors access to many of the world’s very best primary fund, secondary fund, and co-investment opportunities. With approximately 3 USD billion in assets under management, Northgate is privileged to have a select group of loyal, sophisticated, and demanding institutional and family investors as its limited partners.